Open Access Open Access  Restricted Access Subscription Access

Antimicrobial Nanotechnologies:What Are the Current Possibilities?


Affiliations
1 Pharmacognosy and Ethnopharmacology Division, CSIR-National Botanical Research Institute, Lucknow 226 001, India
2 Centre of Excellence in Materials Science (Nanomaterials), Z.H. College of Engineering and Technology, Aligarh Muslim University, Aligarh 202 002, India
 

The current challenges of multi-drug resistance development in human pathogenic microorganisms are engaging researchers in exploring the field of nanotechnology-derived approaches and products as new tools of key developments for manufacturing effective antimicrobials. But, the real contributions are still uncertain. Although there are several budding leads of nanotechnology and the growing trends in publications and patents, therapeutic microbiological applications have not yet made it to the market. Numerous reasons could explain the scarcity of commercial applications. These include high initial production investments, new nanotechnology regulation in the developed and developing countries, and public perception. The rapid progress of nanotechnology in other key areas may over time be transferred to therapeutic microbiological applications as well, and accelerate their development.
User
Notifications
Font Size

Abstract Views: 387

PDF Views: 126




  • Antimicrobial Nanotechnologies:What Are the Current Possibilities?

Abstract Views: 387  |  PDF Views: 126

Authors

Brahma N. Singh
Pharmacognosy and Ethnopharmacology Division, CSIR-National Botanical Research Institute, Lucknow 226 001, India
Prateeksha
Pharmacognosy and Ethnopharmacology Division, CSIR-National Botanical Research Institute, Lucknow 226 001, India
Ch. V. Rao
Pharmacognosy and Ethnopharmacology Division, CSIR-National Botanical Research Institute, Lucknow 226 001, India
A. K. S. Rawat
Pharmacognosy and Ethnopharmacology Division, CSIR-National Botanical Research Institute, Lucknow 226 001, India
Dalip K. Upreti
Pharmacognosy and Ethnopharmacology Division, CSIR-National Botanical Research Institute, Lucknow 226 001, India
Braj R. Singh
Centre of Excellence in Materials Science (Nanomaterials), Z.H. College of Engineering and Technology, Aligarh Muslim University, Aligarh 202 002, India

Abstract


The current challenges of multi-drug resistance development in human pathogenic microorganisms are engaging researchers in exploring the field of nanotechnology-derived approaches and products as new tools of key developments for manufacturing effective antimicrobials. But, the real contributions are still uncertain. Although there are several budding leads of nanotechnology and the growing trends in publications and patents, therapeutic microbiological applications have not yet made it to the market. Numerous reasons could explain the scarcity of commercial applications. These include high initial production investments, new nanotechnology regulation in the developed and developing countries, and public perception. The rapid progress of nanotechnology in other key areas may over time be transferred to therapeutic microbiological applications as well, and accelerate their development.


DOI: https://doi.org/10.18520/cs%2Fv108%2Fi7%2F1210-1213